Drug or treatment

Sugemalimab clinical trials

• 5Clinical trials
• 1Country

Newest trials

All recruiting trials (5)

• Sugemalimab plus platinum chemotherapy as first-line treatment for advanced NSCLC in routine care

  This will try sugemalimab together with platinum-based chemotherapy as a first-line treatment for adults with locally advanced or metastatic NSCLC.

  Recruiting Peking Union Medical College · Beijing, Beijing Municipality · NCT07247227

• Sugemalimab with chemotherapy before surgery and continued after for resectable stage II–IIIA non-small cell lung cancer

  This study will test whether giving sugemalimab with chemotherapy before surgery and continuing sugemalimab after surgery helps adults with resectable stage II–IIIA non-small cell lung cancer who do not have EGFR or ALK mutations.

  Recruiting Phase 2 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT06987734

• Comparing AK104 and Sugemalimab for advanced lung cancer treatment

  This study is testing whether a new treatment called AK104 works better than Sugemalimab for people with advanced lung cancer who haven't seen their disease get worse after chemotherapy and radiation.

  Recruiting Phase 3 Akeso · Jinan · NCT06617416

• Combining low-dose radiotherapy with sugemalimab, chemotherapy, and olaparib for treating advanced small-cell lung cancer

  This study is testing a new treatment plan that combines low-dose radiation, a drug called sugemalimab, chemotherapy, and another drug called olaparib to see if it helps people with advanced small-cell lung cancer.

  Recruiting Phase 1/2 Sichuan University · Chengdu, Sichuan · NCT06217757

• Using sugemalimab to treat limited stage small cell lung cancer after chemotherapy and radiotherapy

  This study is testing if the drug sugemalimab can help people with limited stage small cell lung cancer stay cancer-free after they have completed chemotherapy and radiotherapy.

  Recruiting Phase 2/3 Sun Yat-sen University · Guangzhou, Guangdong · NCT05623267

Quick answers

How many clinical trials of Sugemalimab are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 2/3: 1, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →